Stefano Malvolti

782 total citations
23 papers, 277 citations indexed

About

Stefano Malvolti is a scholar working on Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Stefano Malvolti has authored 23 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Health, 12 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in Stefano Malvolti's work include Vaccine Coverage and Hesitancy (12 papers), Virology and Viral Diseases (5 papers) and Research on Leishmaniasis Studies (5 papers). Stefano Malvolti is often cited by papers focused on Vaccine Coverage and Hesitancy (12 papers), Virology and Viral Diseases (5 papers) and Research on Leishmaniasis Studies (5 papers). Stefano Malvolti collaborates with scholars based in Switzerland, United States and United Kingdom. Stefano Malvolti's co-authors include Tania Cernuschi, Martin Friede, Paul M. Kaye, Epke A. Le Rutte, Carsten Mantel, Sakshi Mohan, Paul Revill, Mark Sculpher, Jean‐Pierre Amorij and Dinesh Mondal and has published in prestigious journals such as Science, Clinical Infectious Diseases and Vaccine.

In The Last Decade

Stefano Malvolti

21 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefano Malvolti Switzerland 10 117 101 90 70 61 23 277
Juan C. Vargas-Zambrano France 10 139 1.2× 47 0.5× 74 0.8× 76 1.1× 16 0.3× 26 231
José Geraldo Leite Ribeiro Brazil 7 86 0.7× 166 1.6× 128 1.4× 19 0.3× 66 1.1× 15 270
M.-P. Preziosi France 8 293 2.5× 22 0.2× 57 0.6× 48 0.7× 59 1.0× 9 410
Maria de Lourdes de Sousa Maia Brazil 8 58 0.5× 50 0.5× 51 0.6× 26 0.4× 26 0.4× 18 160
Olesya Vorontsov Israel 9 84 0.7× 101 1.0× 157 1.7× 40 0.6× 84 1.4× 12 317
Filippo Dragoni Italy 13 53 0.5× 81 0.8× 238 2.6× 17 0.2× 24 0.4× 31 354
María Ubals Spain 8 73 0.6× 66 0.7× 180 2.0× 22 0.3× 17 0.3× 14 335
Raju Shah India 9 80 0.7× 27 0.3× 69 0.8× 27 0.4× 13 0.2× 26 245
Lauren Levitz United States 8 148 1.3× 75 0.7× 49 0.5× 48 0.7× 68 1.1× 13 277
Melina Georgousakis Australia 9 165 1.4× 116 1.1× 102 1.1× 42 0.6× 28 0.5× 11 301

Countries citing papers authored by Stefano Malvolti

Since Specialization
Citations

This map shows the geographic impact of Stefano Malvolti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Malvolti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Malvolti more than expected).

Fields of papers citing papers by Stefano Malvolti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Malvolti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Malvolti. The network helps show where Stefano Malvolti may publish in the future.

Co-authorship network of co-authors of Stefano Malvolti

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Malvolti. A scholar is included among the top collaborators of Stefano Malvolti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Malvolti. Stefano Malvolti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Malvolti, Stefano, et al.. (2025). Identification and sizing of the current use cases for seasonal influenza vaccines. Vaccine. 60. 127233–127233. 2 indexed citations
4.
Mvundura, Mercy, Christopher J. Gregory, Mateusz Hasso-Agopsowicz, et al.. (2024). An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income Countries. Vaccines. 12(9). 1075–1075. 4 indexed citations
5.
Prem, Kiesha, Tania Cernuschi, Stefano Malvolti, Marc Brisson, & Mark Jit. (2024). Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countries. EClinicalMedicine. 74. 102735–102735. 3 indexed citations
7.
Malvolti, Stefano, Paul Bloem, D. Scott LaMontagne, et al.. (2023). The Global Demand and Supply Balance of the Human Papillomavirus Vaccine: Implications for the Global Strategy for the Elimination of Cervical Cancer. Vaccines. 12(1). 4–4. 5 indexed citations
8.
Malvolti, Stefano, Carsten Mantel, Robin Biellik, et al.. (2023). Estimating the future global dose demand for measles–rubella microarray patches. Frontiers in Public Health. 10. 1037157–1037157. 9 indexed citations
9.
Fu, Han, Kaja Abbas, Stefano Malvolti, et al.. (2023). Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation. BMJ Global Health. 8(11). e012204–e012204. 11 indexed citations
10.
Kaye, Paul M., Greg Matlashewski, Sakshi Mohan, et al.. (2023). Vaccine value profile for leishmaniasis. Vaccine. 41. S153–S175. 22 indexed citations
11.
Malvolti, Stefano, Carsten Mantel, Courtney Jarrahian, et al.. (2023). Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification. Frontiers in Public Health. 11. 1165110–1165110. 9 indexed citations
12.
Mohan, Sakshi, et al.. (2022). Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates. PLoS neglected tropical diseases. 16(6). e0010471–e0010471. 23 indexed citations
13.
Cernuschi, Tania, et al.. (2022). Improving access to human papillomavirus vaccines: A case study in the IA2030 core principle of partnership. Vaccine. 42. S118–S123. 1 indexed citations
14.
15.
Malvolti, Stefano, et al.. (2021). Human leishmaniasis vaccines: Use cases, target population and potential global demand. PLoS neglected tropical diseases. 15(9). e0009742–e0009742. 26 indexed citations
16.
Malvolti, Stefano, et al.. (2021). A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group BStreptococcusVaccines for Pregnant Women. Clinical Infectious Diseases. 74(Supplement_1). S70–S79. 5 indexed citations
17.
Rutte, Epke A. Le, Luc E. Coffeng, Stefano Malvolti, Paul M. Kaye, & Sake J. de Vlas. (2020). The potential impact of human visceral leishmaniasis vaccines on population incidence. PLoS neglected tropical diseases. 14(7). e0008468–e0008468. 16 indexed citations
18.
Malvolti, Stefano, Thomas Cherian, Noni E. MacDonald, et al.. (2020). Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives. Vaccine. 38(33). 5372–5378. 11 indexed citations
19.
Cherian, Thomas, Carsten Mantel, Stefano Malvolti, et al.. (2020). Global Vaccine Action Plan lessons learned III: Monitoring and evaluation/accountability framework. Vaccine. 38(33). 5379–5383. 12 indexed citations
20.
Cernuschi, Tania, et al.. (2017). Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance. Vaccine. 36(4). 498–506. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026